4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Amneal Pharmaceuticals, Inc. (AMRX) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Bridgewater, United States with about 8,700 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, AMRX reported $3.0B in revenue and $72M in net income.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally.
Interactive charts & full statements → Open the AMRX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $3.0B | $2.8B | $2.4B | $2.2B | — |
| Gross Profit | $1.1B | $1.0B | $821M | $785M | — |
| Operating Income (EBIT) | $398M | $348M | $239M | $189M | — |
| Net Income | $72M | ($117M) | ($84M) | ($130M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $722M | $814M | $784M | $724M | $695M | — |
| Gross Profit | $320M | $297M | $274M | $286M | $256M | — |
| Operating Income (EBIT) | $148M | $114M | $70M | $112M | $101M | — |
| Net Income | $62M | $35M | $2M | $22M | $12M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $3.7B | $3.5B | $3.5B | $3.8B | — |
| Total Liabilities | $3.7B | $3.6B | $3.5B | $3.6B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AMRX viewer.
About TickerBase · Data methodology & sources